Cannabis company Aleafia to buy Emblem for 27% premium, in a C$173.2 million deal
Aleafia Health Inc. announced Wednesday a deal to buy fellow Canada-based cannabis company Emblem Corp. in a deal that values Emblem at about C$173.2 million ($128.8 million). Under terms of the deal, Emblem shareholders will receive 0.8377 Aleafia shares for each Emblem share they own. Based on Tuesday's stock closing prices in Canada, that values Emblem shares at C$1.206, or a 27% premium. The deal, which the companies say will create the largest medical cannabis clinic network, gives Aleafia... Читать дальше...